Research Article | Open Access | 10.31586/CardiovascularDisease.0204.03

Hyperuricaemia and other cardiometabolic risks among type 2 diabetes patients


Cardiovascular disease (CVD) is a leading cause of further morbidity and mortality in type 2 diabetes patients. This study aimed to find the serum lipid profile, serum uric acid levels, other CVD risk factors, and how these factors are affected by diabetes duration in adults with type 2 diabetes. The cross-sectional study, involving 100 subjects, was carried out at the Diabetes Centre, Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana. Adult type 2 diabetes patients, 20 years or older, were recruited for the study. The National Cholesterol Education Program (NCEP) Adult Panel III and American Diabetes Association (ADA) guidelines were used to find the metabolic status of the patients. Of the 100 patients, 74% and 62% had high systolic blood pressure and abdominal obesity, respectively. Also, high LDL-cholesterol and hypercholesterolaemia were found in 47% and 46% of the patients, respectively. Forty-six percent (46%) of the patients were hyperuricaemic. Cardiovascular disease risk increased with age from 20 to 79 years. The female diabetics had more adverse CVD risk profile than the male diabetics (high LDL, 55% vs. 23.1%; high total cholesterol, 54.1% vs. 23.1%; high triglycerides, 32.4% vs. 30.8%; low HDL, 25.7% vs. 3.8%). Fifty percent (50%) of females compared to 34.6% of males were hyperuricaemic. However, hypertension was more prevalent among males (systolic blood pressure, 76.9%; diastolic blood pressure, 38.5%) than among females (systolic blood pressure, 73%; diastolic blood pressure, 37.8%). In conclusion, the prevalence of hyperuricaemia and other cardiometabolic risks was high among type 2 diabetes patients.


Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007; 30:162-172
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364:685-696
Adinortey MB, Gyan BE, Adjimani J, Nyarko P, Sarpong C, Tsikata FY et al. Dyslipidaemia associated with type 2 diabetics with micro and macrovascular complications among Ghanaians. Ind J Clin Biochem. 2011; 26(3):261-268
Danquah I, Bedu-Addo G, Terpe K, Micah F, Amoako YA, Awuku YA et al. Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health 2012; 12:210-217
Gibbons GF. Hyperlipidaemia of diabetes. Clin Sci. 1988;71:477-486
Haffner SM. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am J Cardiol. 2002; 90(8A):55i-61i
Mathura KC, Vaidya B, Gurbacharya DL. Study of serum lipid profile in type 2 diabetic patients attending KMCTH. Nepal Med Coll J. 2005; 7(2):97-100
Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J et al. Total cholesterol/HDL-cholesterol ratio versus LDL cholesterol/HDL cholesterol ratio as indices of ischaemic heart disease risk in men. The Quebec cardiovascular study. Arch Intern Med. 2001; 161: 2685-2692
Ryu KA, Kang HH, Kim SY, Yoo MK, Kim JS, Lee CH, Wie GA. Comparison of nutrient intake and diet quality between hyperuricemia subjects and controls in Korea. Clin Nutr Res. 2014; 3:56-63
Kim ES, Kwon HS, Ahn CW, Lim DJ, Shin JA, Lee SH et al. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications 2011; 25(5):309-313
Chien K, Chen M, Hsu H, Chang W, Su T, Lee Y, Hu FB. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem. 2008; 54(2):310-316
Mourad J. The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target. Vascular Health and Risk Management 2008; 4(6):1315-1325
Benetos A, Zureik M, Morcet J, Thomas F, Bean K, Safar M et al. Decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol. 2000; 35:673?680
Bays, HE, Chapman, RH, Grandy, S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidemia: comparison of data from two national surveys. Int J Clin Pract. 2007; 61 (5):737-747
Pasco JA, Nicholson GC, Brennan SLQ, Kotowic MA. Prevalence of obesity and the relationship between the body mass index and body fat: Cross-sectional, population-based data. PLoS ONE 2012; 7(1):e29580
Haffner SM, Stern MP, Hazuda HP, Pugh J, Patterson JK. Do upper body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non-insulin-dependent diabetes mellitus, lipids, and lipoproteins. Diabetes 1987; 36:43-51
Hou X, Lu J, Weng J, Ji L, Shan Z, Liu J. et al. Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: A national diabetes and metabolic disorders survey. PLoS ONE 2013; 8(3): e57319
Adamu MS, Owiredu WKBA, Plange-Rhule J. Metabolic syndrome in relation to body mass index and waist to hip ratio; a study in Kumasi Metropolis. J Obes Weight Loss Ther. 2014;4(1):211-219
Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract. 2002;56:197-205
Amoah AG. Sociodemographic variations in obesity among Ghanaian adults. Public Health Nutr. 2003;6:751-757
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem. 1972;18:499-502
Shankar Prasad DS, Shruti P, Manjula R, Mamatha BV. Study of serum uric acid levels in type 2 diabetes mellitus without complications. Medica Innovatica 2013;2:72-76
World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. 1999 []
Adam IK, Sheye FA, Magami SM, Yusuf MB. Uric acid profile in apparently healthy people and diabetics. European Journal of Chemistry 2012;3(1):10?12
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-3421
American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2014; 37(1):S14-S80
Jha N. A comparative study of coronary and contributory risk factors in rural and urban type 2 diabetics. Kathmandu Univ Med J. 2004;2(1):28-34
Kamath A, Shivaprakash G, Adhikari P. Body mass index and waist circumference in type 2 diabetes mellitus patients attending a diabetes clinic. Int J Biol Med Res. 2011;2(3):636-638
Awa WL, Fach E, Krakow D, Welp R, Kunder J, Voll A et al. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120 183 patients from the German/Austrian DPV database. European Journal of Endocrinology 2012;167:245?254
Gautier A, Roussel R, Ducluzeau PH, Lange C, Vol S, Balkau B et al. Increases in waist circumference and weight as predictors of type 2 diabetes in individuals with impaired fasting glucose: influence of baseline BMI data from the DESIR study. Diabetes Care 2010;33:1850?1852
Meigs JB, Wilson PW, Nathan DM, D?Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160-2167
Hu J, Wallace DC, Jones E, Liu H. Cardiometabolic health of Chinese older adults with diabetes living in Beijing, China. Public Health Nursing 2009;26 (6):500-511
Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetology & Metabolic Syndrome 2010;2:1-5
Al-mukhtar SB, Fadhil NN, Hanna BE. Serum lipid profile in subjects with type 2 diabetes mellitus and hypertension in relation to metabolic syndrome: a case control study. Duhok Med J. 2012;6(2):29-44
Wang J, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005;45:907-913
Codario RA. Risk reduction in diabetic patient. In: Skolink NS, editor. Type 2 Diabetes, Pre-diabetes, and the Metabolic Syndrome. 2nd ed. Humana Press, Springer. New York; 2011. p. 297
Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in native African type-2 diabetic patients. J Natl Med Assoc. 2005;97:557-563
Wang J, Chen R, Lei L, Song Q, Zhang R, Li Y et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China. Asia Pac J Clin Nutr. 2013;22(4):590- 598
Pathak, R, Pathak A. Study of lifestyle habits on risk of type 2 diabetics. Int. J App Basic Med Res. 2012;2: 92-96
Ogbera AO, Fasanmade OA, Chinenye S, Akinlade A. Characterization of lipid parameters in diabetes mellitus - a Nigerian report. International Archives of Medicine 2009;2:19-25
Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332(7533):73-78
Juutilainen A, Kortelainen S, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 27:2898-2904
Canoy D, Cairns BJ, Balkwill A, Wright FL, Green J, Reeves G, Beral V. Body mass index and incident coronary heart disease in women: a population-based prospective study. BMC Medicine 2013;11:87-96
Hernandez-Ono A, Monter-Carreola G, Zanora-Gonzalez J, Cardoso-Saldana G, Posadas-Sanchez R, Torres-Tamayo M, Posadas-Romero C. Association of visceral fat with coronary risk factors in a population-based sample of postmenopausal women. Int J Obes Relat Metab Disord. 2002;26(1):33-39


Download data is not yet available.
  • Views 3
  • Downloads 31
  • Citations 1
  • Shares 0
December 30, 2015
How to Cite
CHIKWERE, Prince; NSIAH, Kwabena; A. TANDOH, Marina. Hyperuricaemia and other cardiometabolic risks among type 2 diabetes patients. Trends Journal of Sciences Research, [S.l.], v. 2, n. 4, p. 126-133, dec. 2015. ISSN 2377-8083. Available at: <>. Date accessed: 25 mar. 2019.